G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

Prior treatment

• Patient is a current alcohol or drug abuser.

Other illness

• Patient has a metabolic disorder that may impair bone formation.
• Patient has distant foci of infections which may spread to the implant site or patient with infection, sepsis or osteomyelitis.
• Patient has a vascular insufficiency, muscular atrophy, or neuromuscular disease
• Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions.

Other

• Patient presents with osteoporosis, which in the opinion of the Principal Investigator, may limit the subject's ability to support total hip arthroplasty using the study device.
• Patient has osteomalacia.
• Patient has rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.
• Patient is a prisoner.
• Patient is pregnant.

• Patient must be a legal adult who has reached full skeletal maturity.
• Patient must be treated for one of the following indications:
• Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
• Rheumatoid arthritis
• Correction of functional deformity
• Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
• Revision procedures where other treatment or devices have failed
• Patient must be able and willing to complete the protocol required follow-up visits.
• Patient must be able and willing to sign the Institutional Review Board or Ethics Committee (IRB/EC) approved informed consent.